# Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)

Study · id `cardio:ct-nct05198791` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05198791](<https://clinicaltrials.gov/study/NCT05198791>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05198791

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 2 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 379 participants.

## Technical summary

Registry record NCT05198791. Randomized; double masking; primary purpose treatment. Start 2022-02-04 (actual); primary completion 2026-11-18 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Phase 2
- Enrolled: 379 participants (enrolled count; ClinicalTrials.gov record NCT05198791, source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)
- Started: 2022-02-04 (actual) (ClinicalTrials.gov record NCT05198791, source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)
- Primary completion: 2026-11-18 (anticipated) (ClinicalTrials.gov record NCT05198791, source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)
- Completion: 2030-07-31 (anticipated) (ClinicalTrials.gov record NCT05198791, source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)
- Countries: United Kingdom (ClinicalTrials.gov record NCT05198791, source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05198791-2026-11-18`, retrieved 2026-11-18)

## The registry's words

- Brief title: Stratified Medicine of Eplerenone in Acute Myocardial Infarction or Injury and no Obstructive Coronary Arteries (StratMed-MINOCA)
- Acronym: StratMedMINOCA
- Condition: Myocardial Infarction, Acute
- Condition: Myocardial Infarction With Nonobstructive Coronary Arteries
- Condition: Myocardial Injury
- Intervention (Drug): Stratified medicine - Microvascular dysfunction and eplerenone therapy, tablets
- Intervention (Other): Stratification and standard care
- Lead sponsor: NHS National Waiting Times Centre Board
- Lead sponsor class: OTHER
- Collaborator: British Heart Foundation
- Collaborator class: OTHER
- Collaborator: Abbott
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry lists this organization as the lead sponsor: NHS National Waiting Times Centre Board (`cardio:org-nhs-national-waiting-times-centre-board`)
- Registry lists this organization as a collaborator: British Heart Foundation (`cardio:org-british-heart-foundation`)
- Registry lists this organization as a collaborator: Abbott (`cardio:abbott`)

## Provenance

Content hash: 2f0da36768b2361ec96f14f0291652a21549507035ac087861d9818bb3df3bdf
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
